Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Amoxicillin And Clavulanate Potassium Tablet, Multilayer, Extended Release while breastfeeding. We will also discuss about common side effects and warnings associated with Amoxicillin And Clavulanate Potassium Tablet, Multilayer, Extended Release.
What is Amoxicillin And Clavulanate Potassium Tablet, Multilayer, Extended Release ?
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Amoxicillin and Clavulanate Potassium Extended Release Tablets and other antibacterial drugs, Amoxicillin and Clavulanate Potassium Extended Release Tablets should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Amoxicillin and Clavulanate Potassium Extended Release Tablets are indicated for the treatment of patients with community-acquired pneumonia or acute bacterial sinusitis due to confirmed, or suspected β-lactamase–producing pathogens (i.e., H. influenzae, M. catarrhalis, H. parainfluenzae, K. pneumoniae, or methicillin-susceptible S. aureus) and S. pneumoniae with reduced susceptibility to penicillin (i.e., penicillin MICs = 2 mcg/mL). Amoxicillin and Clavulanate Potassium Extended Release Tablets are not indicated for the treatment of infections due to S. pneumoniae with penicillin MICs ≥ 4 mcg/mL. Data are limited with regard to infections due to S. pneumoniae with penicillin MICs ≥ 4 mcg/ml [see Clinical Studies ( 14 )]. In patients with community-acquired pneumonia in whom penicillin-resistant S. pneumoniae is suspected, bacteriological studies should be performed to determine the causative organisms and their susceptibility when Amoxicillin and Clavulanate Potassium Extended Release Tablets are prescribed. Acute bacterial sinusitis or community-acquired pneumonia due to a penicillin- susceptible strain of S. pneumoniae plus a β-lactamase–producing pathogen can be treated with another Amoxicillin and Clavulanate Potassium product containing lower daily doses of amoxicillin (i.e., 500 mg every 8 hours or 875 mg every 12 hours). Acute bacterial sinusitis or community-acquired pneumonia due to S. pneumoniae alone can be treated with amoxicillin. Amoxicillin and Clavulanate Potassium Extended Release Tablets are a combination of a penicillin-class antibacterial drug and a beta-lactamase inhibitor indicated for treatment of community-acquired pneumonia and acute bacterial sinusitis (1).
Is using Amoxicillin And Clavulanate Potassium Tablet, Multilayer, Extended Release safe or dangerous while breastfeeding?
Amoxicillin And Clavulanate Potassium Tablet, Multilayer, Extended Release consists three active ingredients namely Amoxicillin anhydrous,Amoxicillin anhydrous and Clavulanic acid. Our study of all three ingredients suggest that exposure of Amoxicillin And Clavulanate Potassium Tablet, Multilayer, Extended Release is mostly safe while breastfeeding. Although it is safe to use Amoxicillin And Clavulanate Potassium Tablet, Multilayer, Extended Release in lactation but also recommend you to go through the analysis of all three ingredients as below.
Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers Amoxicillin has been shown to be excreted in human milk; therefore, caution should be exercised when Amoxicillin and Clavulanate Potassium Extended Release Tablets is administered to a nursing woman.
Amoxicillin And Clavulanate Potassium Tablet, Multilayer, Extended Release Breastfeeding Analsys
SafeCAS Number: 26787-78-0
Excretion into breast milk is insignificant and no adverse effects reported in breasted infants. Es considerada medicación compatible con la lactancia por autores y sociedades científicas relevantes (Rowe 2013, Nahum 2006, Mahadevan 2006, Bar-Oz 2003, CDC 2001, Fulton 1992). Es una medicación de uso común en Pediatría y considerado medicamento esencial para uso pediátrico por la OMS (WHO 2013). The possible negativity of cultures in febrile infants whose mothers take antibiotics should be taken into account, as well as the possibility of gastroenteritis due to altered intestinal flora (Benyamini 2005, Ito 1993, Kafetzis 1981). American Academy of Pediatrics: medication usually compatible with breastfeeding (AAP 2001).List of WHO essential medicines: compatible with breastfeeding (WHO / UNICEF 2002).
SafeCAS Number: 26787-78-0
Excretion into breast milk is insignificant and no adverse effects reported in breasted infants. Es considerada medicación compatible con la lactancia por autores y sociedades científicas relevantes (Rowe 2013, Nahum 2006, Mahadevan 2006, Bar-Oz 2003, CDC 2001, Fulton 1992). Es una medicación de uso común en Pediatría y considerado medicamento esencial para uso pediátrico por la OMS (WHO 2013). The possible negativity of cultures in febrile infants whose mothers take antibiotics should be taken into account, as well as the possibility of gastroenteritis due to altered intestinal flora (Benyamini 2005, Ito 1993, Kafetzis 1981). American Academy of Pediatrics: medication usually compatible with breastfeeding (AAP 2001).List of WHO essential medicines: compatible with breastfeeding (WHO / UNICEF 2002).
Amoxicillin And Clavulanate Potassium Tablet, Multilayer, Extended Release Breastfeeding Analsys - 2
CAS Number: 26787-78-0
Limited information indicates that amoxicillin produces low levels in milk that are not expected to cause adverse effects in breastfed infants. Occasionally, rash and disruption of the infant's gastrointestinal flora, resulting in diarrhea or thrush, have been reported, but these effects have not been adequately evaluated. Amoxicillin is acceptable in nursing mothers. Amoxicillin powder for suspension reconstituted with breastmilk is absorbed as well as the powder reconstituted with water.[1]
CAS Number: 26787-78-0
Limited information indicates that amoxicillin produces low levels in milk that are not expected to cause adverse effects in breastfed infants. Occasionally, rash and disruption of the infant's gastrointestinal flora, resulting in diarrhea or thrush, have been reported, but these effects have not been adequately evaluated. Amoxicillin is acceptable in nursing mothers. Amoxicillin powder for suspension reconstituted with breastmilk is absorbed as well as the powder reconstituted with water.[1]
CAS Number: 86482-18-0
Limited information indicates that ticarcillin produces low levels in milk that are not expected to cause adverse effects in breastfed infants. Clavulanic acid has not been studied in nursing mothers. Occasionally disruption of the infant's gastrointestinal flora, resulting in diarrhea or thrush have been reported with penicillins, but these effects have not been adequately evaluated. Ticarcillin and clavulanic acid is acceptable is acceptable in nursing mothers.
Amoxicillin And Clavulanate Potassium Tablet, Multilayer, Extended Release Breastfeeding Analsys - 3
Clavulanic acid and Breastfeeding
Safe
What should I do if already breastfed my kid after using Amoxicillin And Clavulanate Potassium Tablet, Multilayer, Extended Release?
It is always a good idea to keep your healthcare provider or doctor informed about your drug usage during pregnancy and breastfeeding but if you have not informed your doctor about Amoxicillin And Clavulanate Potassium Tablet, Multilayer, Extended Release and have used it then do not panic as Amoxicillin And Clavulanate Potassium Tablet, Multilayer, Extended Release is mostly safe in breastfeeding and should not cause any harm to your baby.
My doctor has prescribed me Amoxicillin And Clavulanate Potassium Tablet, Multilayer, Extended Release, what should I do?
Usage of Amoxicillin And Clavulanate Potassium Tablet, Multilayer, Extended Release is safe for nursing mothers and baby, No worries.
If I am using Amoxicillin And Clavulanate Potassium Tablet, Multilayer, Extended Release, will my baby need extra monitoring?
No
Who can I talk to if I have questions about usage of Amoxicillin And Clavulanate Potassium Tablet, Multilayer, Extended Release in breastfeeding?
US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week